IL1B and trigeminal nerve disorder: In a trigeminal neuralgia model established by trigeminal nerve root compression, BoNT/A administration reduced levels of inflammatory cytokines in TG, specifically IL-1β, IL-6, and TNF-α [43] (Figure 6).